Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study

NCT00649961 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT00649961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00649961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study
Lead sponsor
Imperial College London
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
February 28, 2011
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain injury, premature birth